Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lifespin is a health diagnostics company based in Germany that specializes in digitizing the human metabolome using Nuclear Magnetic Resonance (NMR) spectroscopy. By combining NMR technology with proprietary artificial intelligence and a vast database of metabolic profiles, the company creates digital twins of patient metabolism to identify disease-specific patterns. Their platform is designed to provide highly scalable, cost-effective, and precise diagnostic tools for early detection and monitoring of chronic diseases. Lifespin's current portfolio focuses on neurological disorders like Multiple Sclerosis and Parkinson's, as well as various forms of cancer and metabolic conditions. The company aims to replace traditional single-biomarker tests with comprehensive metabolic snapshots to improve patient outcomes and drug development processes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lifespin Health.